{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:22:18Z","timestamp":1760368938264},"reference-count":0,"publisher":"Wiley","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharmacol Ther"],"published-print":{"date-parts":[[1989,5]]},"DOI":"10.1038\/clpt.1989.66","type":"journal-article","created":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T12:47:04Z","timestamp":1283172424000},"page":"513-519","source":"Crossref","is-referenced-by-count":64,"title":["Sublingual versus subcutaneous buprenorphine in opiate abusers"],"prefix":"10.1111","volume":"45","author":[{"given":"Donald R","family":"Jasinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Fudala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolley E","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","container-title":["Clinical Pharmacology and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:18:39Z","timestamp":1699363119000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1038\/clpt.1989.66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["clpt198966"],"URL":"https:\/\/doi.org\/10.1038\/clpt.1989.66","relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}